No Data
No Data
Express News | Nuwellis Marks First Commercial Sale of Quelimmune™ Therapy to Cincinnati Children’s
Express News | CMS Grants Category B Coverage for Adults With Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial
CMS Grants Category B Coverage for Adults With Acute Kidney Injury Enrolled in SeaStar Medical's Selective Cytopheretic Device Pivotal Trial
Reimbursement expected to accelerate medical site activations and cover a portion of the Company's NEUTRALIZE-AKI trial costs DENVER, July 16, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding
Sector Update: Health Care Stocks Higher in Late Afternoon Trading
Health care stocks advanced late Friday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.The iShares Biotechnology ETF (IBB) gained 0.8%
Sector Update: Health Care
Health care stocks rose Friday afternoo, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both climbing 0.9%.The iShares Biotechnology ETF (IBB) added 0.9%.In
SeaStar Medical Begins Commercial Sale of Pediatric Acute Kidney Injury Treatment
SeaStar Medical (ICU) reported Friday the first commercial sale of the Quelimmune pediatric product to its US distribution partner Nuwellis (NUWE).The company said the US Food and Drug
No Data